Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06042517 · ClinicalTrials.gov registry record · NA

Mechanisms of Ultrasound Neuromodulation Effects in Diabetes

A NA study of Insulin Sensitivity, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
77
Enrollment target
1
Study location

NCT06042517 is a NA study of Insulin Sensitivity that is actively recruiting participants, run by Yale University. The registered enrollment target is 77 participants, above the 70-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06042517, a NA study of Insulin Sensitivity, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
77 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the effect of hepatic ultrasound treatment on changes from baseline in whole-body insulin sensitivity during a hyperinsulinemic, euglycemic clamp (HE Clamp).

Conditions Studied

Insulin Sensitivity

Interventions

  • DEVICE Ultrasound
  • DIAGNOSTIC_TEST OGTT with unlabeled glucose and liver NMR
  • DIAGNOSTIC_TEST OGTT with carbon-13 labeled glucose and liver NMR
  • DIAGNOSTIC_TEST CGM glucose reading
  • DIAGNOSTIC_TEST HEC - Hyperinsulinemic-Euglycemic-Clamp

Study Locations (1)

Connecticut

  • Yale School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2023-09-30
Est. Completion 2027-09-30
Phase NA

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06042517

The ClinicalTrials.gov registry entry for NCT06042517 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 70-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (10% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insulin Sensitivity appearing as the primary indexed condition, and to 5 interventions - of which Ultrasound is the first listed.

NCT06042517 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06042517 about?

NCT06042517 is a clinical study titled "Mechanisms of Ultrasound Neuromodulation Effects in Diabetes". This study aims to evaluate the effect of hepatic ultrasound treatment on changes from baseline in whole-body insulin sensitivity during a hyperinsulinemic, euglycemic clamp (HE Clamp).

What is the current status of trial NCT06042517?

This trial is currently recruiting. It is a NA study. The enrollment target is 77 participants. The study started on 2023-09-30. Estimated completion is 2027-09-30.

What conditions does trial NCT06042517 study?

This clinical trial studies the following conditions: Insulin Sensitivity.

What interventions are being tested in trial NCT06042517?

The interventions under investigation include: Ultrasound (DEVICE), OGTT with unlabeled glucose and liver NMR (DIAGNOSTIC_TEST), OGTT with carbon-13 labeled glucose and liver NMR (DIAGNOSTIC_TEST), CGM glucose reading (DIAGNOSTIC_TEST), HEC - Hyperinsulinemic-Euglycemic-Clamp (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06042517?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06042517 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Insulin Sensitivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Insulin Sensitivity

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.